This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khanna, C. Articles by Helman, L. Search for Related Content PubMed PubMed Citation Articles by Khanna, C. Articles by Helman, L.

Metastasis-associated Differences in Gene Expression in a Murine Model of Osteosarcoma

Pediatric Oncology [C. K., J. P., J. C., C. Y., L. H.] and Medicine Branches [P. N., J. T.], National Cancer Institute, and Cancer Genetics Branch, Human Genome Research Institute, NIH [J. K., P. M.], Bethesda, Maryland 20892

Despite advances in the management of osteosarcoma (OSA) and other solid tumors, the development of metastasis continues to be the most significant problem and cause of death for cancer patients. To define genetic determinants of pulmonary metastasis, we have applied cDNA microarrays to a recently described murine model of OSA that is characterized by orthotopic tumor growth, a period of minimal residual disease, spontaneous pulmonary metastasis, and cell line variants that differ in metastatic potential. Microarray analysis defined 53 genes (of 3166 unique cDNAs) that were differentially expressed between the primary tumors of the more aggressive (K7M2) and less aggressive (K12) OSA models. By review of the literature, these differentially expressed genes were assigned to six nonmutually exclusive metastasis-associated categories (proliferation and apoptosis, motility and cytoskeleton, invasion, immune surveillance, adherence, and angiogenesis). Functional studies to evaluate K7M2 and K12 for differences in each of these metastasis-associated processes revealed enhanced motility, adherence, and angiogenesis in the more aggressive K7M2 model. For this reason, 10 of the 53 differentially expressed genes that were assigned to the motility and cytoskeleton, adherence, and angiogenesis categories were considered as most likely to define differences in the metastatic behavior of the two models. Ezrin, a gene not described previously in OSA, with functions in motility, invasion, and adherence, was 3-fold overexpressed in K7M2 compared with K12 by microarray. Differential expression for RNA was confirmed by Northern analysis and for protein by immunostaining. Alterations in ezrin protein levels and concomitant cytoskeletal changes in our model confirmed predictions from the arrays. The potential relevance of ezrin in OSA was suggested by its expression in five of five human OSA cell lines. This work represents a rationale approach to the evaluation of microarray data and will be useful to identify genes that may be causally associated with metastasis.

This article has been cited by other articles:

				H. Osawa, C. A. Smith, Y. S. Ra, P. Kongkham, and J. T. Rutka The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells Neuro-oncol, January 1, 2009; 11(4): 381 - 393. [Abstract] [Full Text] [PDF]

				V. D. Leaner, J. F. Chick, H. Donninger, I. Linniola, A. Mendoza, C. Khanna, and M. J. Birrer Inhibition of AP-1 Transcriptional Activity Blocks the Migration, Invasion, and Experimental Metastasis of Murine Osteosarcoma Am. J. Pathol., January 1, 2009; 174(1): 265 - 275. [Abstract] [Full Text] [PDF]

				R. Monni, L. Haddaoui, A. Naba, I. Gallais, M. Arpin, P. Mayeux, and F. Moreau-Gachelin Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia Blood, March 15, 2008; 111(6): 3163 - 3172. [Abstract] [Full Text] [PDF]

				L. Cantiani, M. C. Manara, C. Zucchini, P. De Sanctis, M. Zuntini, L. Valvassori, M. Serra, M. Olivero, M. F. Di Renzo, M. P. Colombo, et al. Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met Signaling Cancer Res., August 15, 2007; 67(16): 7675 - 7685. [Abstract] [Full Text] [PDF]

				N. Gordon, N. V. Koshkina, S.-F. Jia, C. Khanna, A. Mendoza, L. L. Worth, and E. S. Kleinerman Corruption of the Fas Pathway Delays the Pulmonary Clearance of Murine Osteosarcoma Cells, Enhances Their Metastatic Potential, and Reduces the Effect of Aerosol Gemcitabine Clin. Cancer Res., August 1, 2007; 13(15): 4503 - 4510. [Abstract] [Full Text] [PDF]

				T. Cavanna, E. Pokorna, P. Vesely, C. Gray, and D. Zicha Evidence for protein 4.1B acting as a metastasis suppressor J. Cell Sci., February 15, 2007; 120(4): 606 - 616. [Abstract] [Full Text] [PDF]

				C. C. Whiteford, S. Bilke, B. T. Greer, Q. Chen, T. A. Braunschweig, N. Cenacchi, J. S. Wei, M. A. Smith, P. Houghton, C. Morton, et al. Credentialing Preclinical Pediatric Xenograft Models Using Gene Expression and Tissue Microarray Analysis Cancer Res., January 1, 2007; 67(1): 32 - 40. [Abstract] [Full Text] [PDF]

				A. G. Marguiles, V. S. Klimberg, S. Bhattacharrya, D. Gaddy, and L. J. Suva Genomics and Proteomics of Bone Cancer. Clin. Cancer Res., October 15, 2006; 12(20): 6217s - 6221s. [Abstract] [Full Text] [PDF]

				M. Terabe, C. Khanna, S. Bose, F. Melchionda, A. Mendoza, C. L. Mackall, L. J. Helman, and J. A. Berzofsky CD1d-Restricted Natural Killer T Cells Can Down-regulate Tumor Immunosurveillance Independent of Interleukin-4 Receptor-Signal Transducer and Activator of Transcription 6 or Transforming Growth Factor-{beta}. Cancer Res., April 1, 2006; 66(7): 3869 - 3875. [Abstract] [Full Text] [PDF]

				Y. Yu, E. Davicioni, T. J. Triche, and G. Merlino The Homeoprotein Six1 Transcriptionally Activates Multiple Protumorigenic Genes but Requires Ezrin to Promote Metastasis Cancer Res., February 15, 2006; 66(4): 1982 - 1989. [Abstract] [Full Text] [PDF]

				S. de Silva Rudland, L. Martin, C. Roshanlall, J. Winstanley, S. Leinster, A. Platt-Higgins, J. Carroll, C. West, R. Barraclough, and P. Rudland Association of S100A4 and Osteopontin with Specific Prognostic Factors and Survival of Patients with Minimally Invasive Breast Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1192 - 1200. [Abstract] [Full Text] [PDF]

				S.-W. Kim, M. Hayashi, J.-F. Lo, C. Fearns, R. Xiang, G. Lazennec, Y. Yang, and J.-D. Lee Tid1 Negatively Regulates the Migratory Potential of Cancer Cells by Inhibiting the Production of Interleukin-8 Cancer Res., October 1, 2005; 65(19): 8784 - 8791. [Abstract] [Full Text] [PDF]

				X. Wan, A. Mendoza, C. Khanna, and L. J. Helman Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma Cancer Res., March 15, 2005; 65(6): 2406 - 2411. [Abstract] [Full Text] [PDF]

				Y. Cao, Z. Zhou, B. de Crombrugghe, K. Nakashima, H. Guan, X. Duan, S.-F. Jia, and E. S. Kleinerman Osterix, a Transcription Factor for Osteoblast Differentiation, Mediates Antitumor Activity in Murine Osteosarcoma Cancer Res., February 15, 2005; 65(4): 1124 - 1128. [Abstract] [Full Text] [PDF]

				B. L. Eckhardt, B. S. Parker, R. K. van Laar, C. M. Restall, A. L. Natoli, M. D. Tavaria, K. L. Stanley, E. K. Sloan, J. M. Moseley, and R. L. Anderson Genomic Analysis of a Spontaneous Model of Breast Cancer Metastasis to Bone Reveals a Role for the Extracellular Matrix Mol. Cancer Res., January 1, 2005; 3(1): 1 - 13. [Abstract] [Full Text] [PDF]

				T. J. Belbin, B. Singh, R. V. Smith, N. D. Socci, V. B. Wreesmann, M. Sanchez-Carbayo, J. Masterson, S. Patel, C. Cordon-Cardo, M. B. Prystowsky, et al. Molecular Profiling of Tumor Progression in Head and Neck Cancer Arch Otolaryngol Head Neck Surg, January 1, 2005; 131(1): 10 - 18. [Abstract] [Full Text] [PDF]

				M. Zou, K. S. Famulski, R. S. Parhar, E. Baitei, F. A. Al-Mohanna, N. R. Farid, and Y. Shi Microarray Analysis of Metastasis-Associated Gene Expression Profiling in a Murine Model of Thyroid Carcinoma Pulmonary Metastasis: Identification of S100A4 (Mts1) Gene Overexpression as a Poor Prognostic Marker for Thyroid Carcinoma J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6146 - 6154. [Abstract] [Full Text] [PDF]

				J. Pinkas, S. S. Martin, and P. Leder Bcl-2-Mediated Cell Survival Promotes Metastasis of EpH4 {beta}MEKDD Mammary Epithelial Cells Mol. Cancer Res., October 1, 2004; 2(10): 551 - 556. [Abstract] [Full Text] [PDF]

				M. Abdel-Ghany, H.-C. Cheng, R. C. Elble, H. Lin, J. DiBiasio, and B. U. Pauli The Interacting Binding Domains of the {beta}4 Integrin and Calcium-activated Chloride Channels (CLCAs) in Metastasis J. Biol. Chem., December 5, 2003; 278(49): 49406 - 49416. [Abstract] [Full Text] [PDF]

				R. Gorlick, P. Anderson, I. Andrulis, C. Arndt, G. P. Beardsley, M. Bernstein, J. Bridge, N.-K. Cheung, J. S. Dome, D. Ebb, et al. Biology of Childhood Osteogenic Sarcoma and Potential Targets for Therapeutic Development: Meeting Summary Clin. Cancer Res., November 15, 2003; 9(15): 5442 - 5453. [Abstract] [Full Text] [PDF]

				W. B. Sneddon, C. A. Syme, A. Bisello, C. E. Magyar, M. D. Rochdi, J.-L. Parent, E. J. Weinman, A. B. Abou-Samra, and P. A. Friedman Activation-independent Parathyroid Hormone Receptor Internalization Is Regulated by NHERF1 (EBP50) J. Biol. Chem., October 31, 2003; 278(44): 43787 - 43796. [Abstract] [Full Text] [PDF]

				S. Kakiuchi, Y. Daigo, T. Tsunoda, S. Yano, S. Sone, and Y. Nakamura Genome-Wide Analysis of Organ-Preferential Metastasis of Human Small Cell Lung Cancer in Mice Mol. Cancer Res., May 1, 2003; 1(7): 485 - 499. [Abstract] [Full Text] [PDF]

				P. J. Houghton, P. C. Adamson, S. Blaney, H. A. Fine, R. Gorlick, M. Haber, L. Helman, S. Hirschfeld, M. G. Hollingshead, M. A. Israel, et al. Testing of New Agents in Childhood Cancer Preclinical Models: Meeting Summary Clin. Cancer Res., December 1, 2002; 8(12): 3646 - 3657. [Abstract] [Full Text] [PDF]

				M. S. Bendre, D. Gaddy-Kurten, T. Mon-Foote, N. S. Akel, R. A. Skinner, R. W. Nicholas, and L. J. Suva Expression of Interleukin 8 and not Parathyroid Hormone-related Protein by Human Breast Cancer Cells Correlates with Bone Metastasis in Vivo Cancer Res., October 1, 2002; 62(19): 5571 - 5579. [Abstract] [Full Text] [PDF]

				M. Abdel-Ghany, H.-C. Cheng, R. C. Elble, and B. U. Pauli Focal Adhesion Kinase Activated by beta 4 Integrin Ligation to mCLCA1 Mediates Early Metastatic Growth J. Biol. Chem., September 6, 2002; 277(37): 34391 - 34400. [Abstract] [Full Text] [PDF]

				G. Stapleton, A. Malliri, and B. W. Ozanne Downregulated AP-1 activity is associated with inhibition of Protein-Kinase-C-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells J. Cell Sci., January 7, 2002; 115(13): 2713 - 2724. [Abstract] [Full Text] [PDF]